½ÃÀ庸°í¼­
»óǰÄÚµå
1594534

´©Æ®·ÎÇÈ ½ÃÀå : ÇüÅÂ, À¯Åë ä³Î, ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Nootropics Market by Form (Capsules & Tablets, Drinks, Powder), Distribution Channel (Offline, Online), End Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

´©Æ®·ÎÇÈ ½ÃÀåÀº 2023³â 140¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 151¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 8.39% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 246¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½º¸¶Æ® ¾à¹° ¶Ç´Â ÀÎÁö Çâ»óÁ¦·Îµµ ¾Ë·ÁÁø ´©Æ®·ÎÇÈÀº °Ç°­ÇÑ »ç¶÷ÀÇ ÀÎÁö ±â´É, ±â¾ï·Â, âÀÇ·Â, ÀÇ¿åÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ´Ù¾çÇÑ ¹°ÁúÀ» Æ÷°ýÇÏ´Â °ÍÀ¸·Î, 360iResearchÀÇ ½ÃÀå Á¶»ç ºÐ¼®°¡·Î¼­, °æÀïÀÇ ½ÉÈ­, Á¤½Å°Ç°­¿¡ ´ëÇÑ ÀνÄ, ÀÎÁö °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀνÄ, °í·ÉÈ­ µîÀ¸·Î ÀÎÇØ ´©Æ®·ÎÇÈÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ½À» ÀÌÇØÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ´©Æ®·ÎÇÈÀÇ ¿ëµµ´Â ÀÓ»ó¿¡¼­ °³Àοë±îÁö ´Ù¾çÇϸç, Àü¹®°¡, Çлý, ³ëÀεéÀÌ °¥¸ÁÇÏ´Â ¶ó¼¼Å½, ÀûÀÀÁ¦, Äݸ°¼º ¾à¹°°ú °°Àº º¸ÃæÁ¦±îÁö Æ÷ÇÔÇÕ´Ï´Ù. ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀº Á¤½Å°Ç°­¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½É Áõ°¡, È¿´ÉÀ» °ËÁõÇÏ´Â Áö¼ÓÀûÀÎ ¿¬±¸, Çõ½ÅÀûÀÎ Á¦ÇüÀÇ Á¦Ç° Ãâ½Ã Áõ°¡ µîÀÔ´Ï´Ù. ¶ÇÇÑ, À£ºù ¹× ¶óÀÌÇÁ½ºÅ¸ÀÏ Æ®·»µå´Â õ¿¬ ¹× À¯±â³ó ´©Æ®·ÎÇÈÀÇ °³¹ßÀ» ÃËÁøÇÏ¿© ÀÌ Æ´»õ ½ÃÀå¿¡ ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ½Ä¹°¼º ´©Æ®·ÎÇȰú ÀÇ»çÀÇ µµ¿òÀ» ¹Þ´Â ¸ÂÃãÇü ¼Ö·ç¼ÇÀÇ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÔÀ¸·Î½á ÀÌ·¯ÇÑ Ãß¼¼¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±àÁ¤ÀûÀÎ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, ½ÃÀå¿¡´Â ±ÔÁ¦ Àå¾Ö¹°, Áö¿ªº°·Î »óÀÌÇÑ ±ÔÁ¤ Áؼö ±âÁØ, ½ÇÁúÀûÀÎ ÀÓ»óÀû ±Ù°Å°¡ ¾ø´Â Á¦Ç° ÁÖÀå¿¡ ´ëÇÑ È¸ÀÇÀûÀÎ ½Ã°¢ µî ÇѰ谡 ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñó¹æ °­È­Á¦¿¡ ´ëÇÑ ÀáÀçÀû ºÎÀÛ¿ë°ú À±¸®Àû ¹®Á¦µµ Åõ¸í¼º ÀÖ´Â Ä¿¹Â´ÏÄÉÀ̼ǰú ÀÓ»ó½ÃÇèÀ» ÅëÇØ ÇØ°áÇÏÁö ¾ÊÀ¸¸é ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ¼ºÀåÀ» À§Çؼ­´Â ´©Æ®·ÎÇȰú AI ±â¼úÀÇ ½Ã³ÊÁö¸¦ ÅëÇØ ¼ÒºñÀÚ ÀλçÀÌÆ®¿Í °á°ú¸¦ °³ÀÎÈ­ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀÌ °¡Àå ÁÁÀº Çõ½Å ºÐ¾ß°¡ µÉ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ÇコÄɾî Àü¹®°¡¿ÍÀÇ Çù¾÷Àº ÁøÁ¤ÇÑ ¼ÒºñÀÚ ´ÏÁ ÃæÁ·ÇÏ´Â È¿°úÀûÀÎ Á¦Ç° °³¹ß·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ Á¡Àº ½ÃÀå °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ½ÇÁõÀû ¿¬±¸¿Í Áõ°Å ±â¹Ý ¸¶ÄÉÆÃÀÌ ¼º°øÀÇ ÇÙ½É ¿ä¼Ò·Î ¶°¿À¸£°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. Àü¹ÝÀûÀ¸·Î ½ÃÀå ȯ°æÀº ±â¼ú Çõ½Å, ±ÔÁ¦ »óȲ, ¼ÒºñÀÚÀÇ È¸ÀÇÀûÀÎ ½Ã°¢°ú À±¸®Àû ¿ì·Á¿¡ È¿°úÀûÀ¸·Î ´ëÀÀÇϱâ À§ÇÑ Àü·«Àû ¸¶ÄÉÆÃÀ¸·Î ÀÎÇØ ¿ªµ¿ÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 140¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 151¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 246¾ï 3,000¸¸ ´Þ·¯
CAGR(%) 8.39%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ´©Æ®·ÎÇÈ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù

´©Æ®·ÎÇÈ ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ÀÎÁö ´É·Â Çâ»ó°ú ³ú °Ç°­¿¡ ´ëÇÑ °ü½É Áõ´ë
    • ¿Â¶óÀÎ À¯Åë ä³ÎÀ» ÅëÇÑ ½Å¼ÓÇÑ Á¦Ç° °ø±Þ °¡´É
    • ¼±¼öµé »çÀÌ¿¡¼­ ³ôÀº ä¿ë·ü
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ´©Æ®·ÎÇÈ °ú´Ù º¹¿ëÀ¸·Î ÀÎÇÑ ºÎÀÛ¿ë
  • ½ÃÀå ±âȸ
    • ´©Æ®·ÎÇÈÀÇ ÁøÈ­¸¦ À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß
    • ´©Æ®·ÎÇÈÀÇ È¿°úÀûÀÎ ¸¶ÄÉÆÃ ¹× ±¤°í
  • ½ÃÀå °úÁ¦
    • Á¦Ç° °³¹ß¿¡ ´ëÇÑ Á¤ºÎÀÇ ¾ö°ÝÇÑ ±ÔÁ¦¿Í °¡À̵å¶óÀÎ

Porter's Five Forces : ´©Æ®·ÎÇÈ ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ´©Æ®·ÎÇÈ ½ÃÀåÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ´©Æ®·ÎÇÈ ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ´©Æ®·ÎÇÈ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ´©Æ®·ÎÇÈ ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

´©Æ®·ÎÇÈ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ´©Æ®·ÎÇÈ ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ´©Æ®·ÎÇÈ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

´©Æ®·ÎÇÈ ½ÃÀå¿¡¼­ÀÇ ¼º°ø Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

´©Æ®·ÎÇÈ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ´©Æ®·ÎÇÈ ½ÃÀå : Çüź°

  • ĸ½¶°ú ÅÂºí¸´
  • µå¸µÅ©
  • ºÐ¸»

Á¦7Àå ´©Æ®·ÎÇÈ ½ÃÀå : À¯Åë ä³Îº°

  • ¿ÀÇÁ¶óÀÎ
  • ¿Â¶óÀÎ

Á¦8Àå ´©Æ®·ÎÇÈ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ºÒ¾È
  • ÁÖÀÇ¿Í ÁýÁß
  • Àå¼ö¿Í ¾ÈƼ¿¡ÀÌ¡
  • ±â¾ï·Â °­È­
  • ±âºÐ°ú ¿ì¿ïÁõ
  • ¼ö¸é°ú ȸº¹

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ´©Æ®·ÎÇÈ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´©Æ®·ÎÇÈ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ´©Æ®·ÎÇÈ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Accelerated Intelligence, Inc.
  • AlternaScript, LLC
  • Gaia Herbs Farm
  • Health Via Modern Nutrition Inc.
  • Kimera Koffee
  • Mental Mojo, LLC
  • NooCube
  • Peak Nootropics
  • PowderCity.com,Ltd.
  • Purelife Bioscience Co., Ltd.
  • Reckitt Benckiser Group PLC
  • SupNootropic Biological Technology Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Unilever PLC
  • United Pharmacies
ksm 24.11.28

The Nootropics Market was valued at USD 14.01 billion in 2023, expected to reach USD 15.13 billion in 2024, and is projected to grow at a CAGR of 8.39%, to USD 24.63 billion by 2030.

Nootropics, also known as smart drugs or cognitive enhancers, encompass a range of substances that aim to improve cognitive function, memory, creativity, or motivation in healthy individuals. As a market research analyst at 360iResearch, it's essential to understand the growing necessity of nootropics in the modern era, driven by increasing competition, mental health awareness, and the aging population seeking cognitive health solutions. Applications of nootropics span from clinical settings to personal use, thirsted by professionals, students, and seniors, and including supplements like racetams, adaptogens, and cholinergics. Key drivers of growth are the rising consumer inclination towards mental wellness, ongoing research validating efficacy, and increasing product launches with innovative formulations. Moreover, the wellness and lifestyle trend fosters natural and organic nootropics development, opening up potential opportunities in this niche market. Companies could capitalize on this trend by investing in R&D for plant-based nootropics and physician-backed, personalized solutions. Despite positive growth prospects, the market encounters limitations such as regulatory hurdles, varying compliance standards across regions, and skepticism over product claims without substantial clinical backing. Furthermore, challenges include potential side-effects and ethical concerns regarding non-prescription enhancers, which could stunt growth if not addressed through transparent communication and clinical trials. For business growth, the best areas of innovation lie in exploring synergies between nootropics and AI technology for personalized consumer insights and outcomes. Additionally, collaboration with healthcare professionals can guide effective product development that meets genuine consumer needs. Notably, the market is increasingly competitive, with empirical research and evidence-based marketing being critical factors for success. Overall, the nootropics market is characterized by dynamic growth prospects contingent on innovation, regulatory landscape navigation, and strategic marketing to effectively address consumer skepticism and ethical concerns.

KEY MARKET STATISTICS
Base Year [2023] USD 14.01 billion
Estimated Year [2024] USD 15.13 billion
Forecast Year [2030] USD 24.63 billion
CAGR (%) 8.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nootropics Market

The Nootropics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing focus on improving cognitive performance and brain health
    • Exponential availability of of products through online distribution channels
    • High adoption among athletes
  • Market Restraints
    • Adverse effects of overconsumption of nootropic drugs
  • Market Opportunities
    • Ongoing R&D on advancing nootropics
    • Effective marketing and advertising of nootropics
  • Market Challenges
    • Stringent government regulations and guidelines for product development

Porter's Five Forces: A Strategic Tool for Navigating the Nootropics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nootropics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nootropics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nootropics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nootropics Market

A detailed market share analysis in the Nootropics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nootropics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nootropics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nootropics Market

A strategic analysis of the Nootropics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nootropics Market, highlighting leading vendors and their innovative profiles. These include Accelerated Intelligence, Inc., AlternaScript, LLC, Gaia Herbs Farm, Health Via Modern Nutrition Inc., Kimera Koffee, Mental Mojo, LLC, NooCube, Peak Nootropics, PowderCity.com,Ltd., Purelife Bioscience Co., Ltd., Reckitt Benckiser Group PLC, SupNootropic Biological Technology Co., Ltd., Teva Pharmaceutical Industries Ltd., Unilever PLC, and United Pharmacies.

Market Segmentation & Coverage

This research report categorizes the Nootropics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Capsules & Tablets, Drinks, and Powder.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End Use, market is studied across Anxiety, Attention & Focus, Longevity & Anti-aging, Memory Enhancement, Mood & Depression, and Sleep & Recovery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing focus on improving cognitive performance and brain health
      • 5.1.1.2. Exponential availability of of products through online distribution channels
      • 5.1.1.3. High adoption among athletes
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of overconsumption of nootropic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D on advancing nootropics
      • 5.1.3.2. Effective marketing and advertising of nootropics
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations and guidelines for product development
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nootropics Market, by Form

  • 6.1. Introduction
  • 6.2. Capsules & Tablets
  • 6.3. Drinks
  • 6.4. Powder

7. Nootropics Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. Online

8. Nootropics Market, by End Use

  • 8.1. Introduction
  • 8.2. Anxiety
  • 8.3. Attention & Focus
  • 8.4. Longevity & Anti-aging
  • 8.5. Memory Enhancement
  • 8.6. Mood & Depression
  • 8.7. Sleep & Recovery

9. Americas Nootropics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Nootropics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Nootropics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accelerated Intelligence, Inc.
  • 2. AlternaScript, LLC
  • 3. Gaia Herbs Farm
  • 4. Health Via Modern Nutrition Inc.
  • 5. Kimera Koffee
  • 6. Mental Mojo, LLC
  • 7. NooCube
  • 8. Peak Nootropics
  • 9. PowderCity.com,Ltd.
  • 10. Purelife Bioscience Co., Ltd.
  • 11. Reckitt Benckiser Group PLC
  • 12. SupNootropic Biological Technology Co., Ltd.
  • 13. Teva Pharmaceutical Industries Ltd.
  • 14. Unilever PLC
  • 15. United Pharmacies
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦